跳至主要内容
临床试验/JPRN-UMIN000037029
JPRN-UMIN000037029已完成未知

Identification of biomarkers which reflects the treatments effects of Nivolmab through comprehensive analyses of serum exosmal mRNA derived from the HNSCC patients. - Identification of biomarkers which reflects the treatments effects of Nivolmab through comprehensive analyses of serum exosmal mRNA derived from the HNSCC patients.

Clinical Research Support Center Kyushu0 个研究点目标入组 111 人开始时间: 2019年6月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
111

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Patients who have been given immune checkpoint inhibitors in the past. 2.Patients with ECOG Performance Status 3 or 4 3.Patients under tumor immunotherapy or with plan to be co-administered with other antineoplastic agents. 4.Patients with active double cancer excluding CIS and endoscopically treatable early esophagus cancer. 5.patients judged inappropriate by investigators.

研究者

发起方
Clinical Research Support Center Kyushu

相似试验